Post-COVID diabetes mellitus in cross-sectional study: autoimmune disease with endothelial dysfunction?

Author:

Alieva Anna1,Khalilova Dilovar1,Saidova Saodat1,Salimova Alinur1

Affiliation:

1. Republican Specialized Scientific-and-Practical Medical Centre of Endocrinology named after academician Ya.Kh.Turakulov

Abstract

Abstract Purpose: To study the characteristics of diabetes occurring after COVID-19. Methods: Hemostasis parameters, vitamin D, and beta cell-specific autoantibodies in 70 patients with post-COVID-19-diagnosed diabetes were tested. Results: In our cross-sectional study, we found a relatively high incidence of type 1 DM (16.7%) and LADA (4.76%) among adults who were diagnosed with DM after COVID-19. Adult patients with type 1 DM were younger, predominantly female, and had a high rate of family history of DM. The majorityof patients with type 1 DM had mild COVID-19 and did not use corticosteroids during acute COVID-19. Patients with not only severe but also mild COVID-19 also had a risk for diabetes onset. All patients with newly diagnosed DM had low vitamin D levels, although Uzbekistan has good insolation. New cases of DM were registered within 0 to 24 months after COVID-19. The majority of type 1 cases were registered during the first 2 months and at 15-20 months after acute COVID-19. The incidence of new type 2 DM cases was consistent during the 2-year period after COVID-19. As expected, patients with type 2 had high levels of D-dimer and von Willebrand factor. Type 1 DM patients – both adults and children – also had increased levels of D-dimer and von Willebrand factor. VCAM-1 levels were high in all patients, including children, with the highest levels in patients with LADA, indicating endothelial dysfunction. Conclusion. The increased incidence of type 1 DM with positive diabetes-specific antibodies after COVID-19 indicates damage to islet cells and their components by SARS-CoV-2 with further activation of autoimmune mechanisms. Young females with a family history of DM who were diagnosed with diabetes after COVID-19 should be tested for diabetes-specific antibodies for proper differentiation of the type of the disease and timely insulin treatment. Type 1 DM developed after COVID-19 should be treated as a disease with cardiovascular disease with endothelial dysfunction.

Publisher

Research Square Platform LLC

Reference19 articles.

1. Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis;Zhang T;BMC Med,2022

2. New-Onset Diabetes Mellitus, Hypertension, Dyslipidemia as Sequelae of COVID-19 Infection—Systematic Review;Wrona M;Int J Environ Res Public Health,2022

3. Atkinson MA, Polonsky S, Reed P, Larsen HM, Kronenberg. Shlomo Melmed. Pp 1451–1483.

4. Higher Prevalence of Type 2 Diabetes in Men Than in Women Is Associated With Differences in Visceral Fat Mass;Nordström A;J Clin Endocrinol Metab,2016

5. Risks and burdens of incident diabetes in long COVID: a cohort study;Xie Y;The Lancet Diabetes and Endocrinology,2022

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3